Prediction of periprocedural Bleeding Event during enDoScopIc submucosal DissEction using total thrombus-formation analysis system study

Prediction of periprocedural Bleeding Event during enDoScopIc submucosal DissEction using total thrombus-formation analysis system study - BEDSIDE study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048592

Enrollment

150

Registered

2022-08-08

Start date

2022-08-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early stage cancer in upper gastrointestinal tract

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo endoscopic submucosal dissection

Exclusion criteria

Exclusion criteria: Patients who refuse to participate, emergent cases, patients who changed antithrombotic therapy within seven days of endoscopic submucosal dissection, patients who used heparin as antithrombotic therapy

Design outcomes

Primary

Measure	Time frame
Hemostasis function assessed by T-TAS, Bleeding events during hospitalization (change of serum hemoglobin level, blood transfusion, unexpected drug withdrawal of antithrombotic drugs), Ischemic events (stroke, myocardial infarction)	—

Countries

Japan

Contacts

Public ContactHirofumi Hioki

Teikyo University Hospital Department of Cardiology

hioki.teikyo@gmail.com03-3964-1211

Outcome results